RU93049678A -
SUSTAINABLE WATER-SOLUBLE VETERINARY PRODUCT AND METHOD FOR PRODUCING IT
- Google Patents
SUSTAINABLE WATER-SOLUBLE VETERINARY PRODUCT AND METHOD FOR PRODUCING IT
Info
Publication number
RU93049678A
RU93049678ARU93049678/15ARU93049678ARU93049678ARU 93049678 ARU93049678 ARU 93049678ARU 93049678/15 ARU93049678/15 ARU 93049678/15ARU 93049678 ARU93049678 ARU 93049678ARU 93049678 ARU93049678 ARU 93049678A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эгиш дьодьсердьар РТ.filedCriticalЭгиш дьодьсердьар РТ.
Publication of RU93049678ApublicationCriticalpatent/RU93049678A/en
Изобретение относится к устойчивому твердому ветеринарному препарату, растворимому в воде, в котором активные вещества представлены натриевой солью сульфахлорпиридазина и триметопримом в соотношении по массе 5 : 1, и к способу получения препарата. Ветеринарный препарат содержит смесь, мас.%: цитрат триметоприма, нанесенного на поверхность частиц водорастворимого твердого носителя, 1,6 - 3,3; сульфахлорпиридазин натрия 8,4 - 16,7; фармацевтически приемлемые добавки, представленные поли(винилпирролидоном) и/или двуокисью кремния.The invention relates to a stable solid veterinary drug, soluble in water, in which the active substances are sodium salt of sulfachloropyridazine and trimethoprim in a ratio by weight of 5: 1, and to a method for producing the drug. The veterinary preparation contains a mixture, wt.%: Trimethoprim citrate deposited on the surface of the particles of a water-soluble solid carrier, 1.6 - 3.3; sodium sulfachloropyridazine 8.4-16.7; pharmaceutically acceptable additives represented by poly (vinylpyrrolidone) and / or silicon dioxide.
RU93049678/15A1992-11-061993-11-03
SUSTAINABLE WATER-SOLUBLE VETERINARY PRODUCT AND METHOD FOR PRODUCING IT
RU93049678A
(en)
SOLID PHARMACEUTICAL PRODUCT CONTAINING A BISMUTH SALT, ADMINISTRABLE BY ORAL ROUTE, PRESENTING AN INCREASED ACTIVITY RATE AND A CONSTANT AND PREDETERMINED SOLUBILITY RATE